GE
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Neural anticipation of virtual infection triggers an immune response | Nature neuroscience | 2025 | 35 | 17 | |||
| Gliadin-reactive vitamin D-sensitive proinflammatory ILCPs are enriched in celiac patients | Cell reports | 2022 | 245 | 169 | |||
| c-Maf enforces cytokine production and promotes memory-like responses in mouse and human type 2 innate lymphoid cells | EMBO journal | 2022 | 381 | 429 | |||
| PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions | Nature Communications | 2021 | 356 | 239 | |||
| Healthy and patient type 2 innate lymphoid cells are differently affected by in vitro culture conditions | Journal of Asthma and Allergy | 2021 | 241 | 84 | |||
| Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer | Science Advances | 2021 | 495 | 335 | |||
| Human primed ILCPs support endothelial activation through NF-κB signaling | eLife | 2021 | 355 | 172 | |||
| Distinct and shared gene expression for human innate versus adaptive helper lymphoid cells | Journal of Leukocyte Biology | 2020 | 409 | 261 | |||
| Immunosuppressive mediators impair proinflammatory innate lymphoid cell function in human malignant melanoma | Cancer Immunology Research | 2020 | 611 | 4 | |||
| ILC2s: new actors in tumor immunity | Frontiers in Immunology | 2019 | 413 | 181 | |||
| Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells | Journal for Immunotherapy of Cancer | 2019 | 366 | 164 |
